Clinical Trial Update: PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for PT-112 combined with gemcitabine in advanced solid tumors (Phase 1/2) ongoing for biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PT-112 (Phosplatin's Platinum) (PT-112)

Snippet

Sponsor: SciClone Pharmaceuticals | Conditions: Biliary Tract Cancer | Phase 1, Phase 2 | Status: UNKNOWN